Cost effectiveness of type 2 diabetes screening: A systematic review
Open Access
- 13 February 2016
- journal article
- Vol. 30, 326
Abstract
Background: Although studies reported diabetes mellitus screening cost effective, the mass screening for type2 diabetes remains controversial. In this study we reviewed the recently evidence about the cost effectiveness of mass screening systematically.Keywords
This publication has 19 references indexed in Scilit:
- Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013The Lancet, 2015
- Cost Effectiveness of Preventive Screening Programmes for Type 2 Diabetes Mellitus in GermanyApplied Health Economics and Health Policy, 2010
- Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysisThe Lancet, 2010
- Mortality attributable to diabetes: Estimates for the year 2010Diabetes Research and Clinical Practice, 2010
- Screening for Type 2 Diabetes Mellitus in Adults: U.S. Preventive Services Task Force Recommendation StatementAnnals of Internal Medicine, 2008
- Cost Effectiveness of Preventive Interventions in Type 2 Diabetes MellitusPharmacoEconomics, 2006
- Screening for Type 2 DiabetesDiabetes Care, 2004
- Screening for Diabetes in General PracticePreventive Cardiology, 2003
- Screening for Type 2 DiabetesDiabetes Care, 2003
- Screening for diabetes mellitus in high-risk patients: cost, yield, and acceptability.2002